Steve Oh | Pioneer and Advisor
Brilliant Research Pte Ltd

Steve Oh, Pioneer and Advisor, Brilliant Research Pte Ltd

Prof. Steve Oh is the Director of Stem Cell Bioprocessing and Institute Professor/Scientist of the Bioprocessing Technology Institute (BTI) and an expert in integrated stem cell bioprocessing for the manufacture of human pluripotent/embryonic and adult mesenchymal stem cells for cell therapies. Key recent achievements include high density production of pluripotent stem cells, cardiomyocytes, neuroprogenitors and red blood cells in suspension bioreactors. In the mesenchymal stem cell (MSC) area, methods of producing high quality MSCs, and primed towards cartilage and bone repair have been achieved. Recently a new assay for stem cell senescence useful for the quality control of stem cells for bioprocesses has been developed by his team. He has over 100 publications and 25 patents in stem cells production. 

He was the International Society of Cellular Therapies (ISCT) Co-Vice President (Asia) from 2015-2017, and led the planning of the Sessions for Commercialisation of Cell Therapies for the Silver Jubilee (25 years) ISCT meeting at Suntec City, Singapore in 2016. He is also the current Vice President of the Singapore Stem Cell Society and holds an Adjunct Professorship at the Nanyang Technological University.

Steve has founded 2 stem cell companies, Brilliant Research and Veristem and is a veteran of 26 years in the biotech industry. Brilliant Research is a company specializing in providing Personalised Stem Cell Banking and Stem Cell Bioprocess solutions to build the 3rd Pillar of Medicine, Cell & Gene Therapies. 

back to speakers

World Advanced Therapies & Regenerative Medicine Congress


Erica Baeta
+44 (0)207 092 1152


Jessica Robinson
t/ +44 (0)207 092 1150


Issa Mauthoor
+44 (0)207 092 1257